Fevrin Medication Guide Comprehensive Overview of Paracetamol Uses Dosage Side Effects and Safety Protocols

Fevrin is a pharmaceutical formulation primarily composed of paracetamol, an active ingredient globally recognized for its efficacy as an analgesic (pain reliever) and antipyretic (fever reducer). As a non-opioid medication, it serves as a frontline treatment for mild to moderate pain and is a staple in both household medicine cabinets and clinical settings. In the Indonesian pharmaceutical market, Fevrin is classified as an over-the-counter (OTC) drug, identifiable by its green circle logo, indicating that it can be purchased without a prescription. However, its accessibility does not diminish the necessity for strict adherence to dosage guidelines, as improper use of paracetamol is a leading cause of drug-induced hepatotoxicity worldwide.

Pharmacological Profile and Mechanism of Action

To understand the utility of Fevrin, one must examine its core component: paracetamol (also known as acetaminophen). Unlike non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin, paracetamol has a weak anti-inflammatory effect. Its primary mechanism of action involves the inhibition of prostaglandin synthesis in the central nervous system. Prostaglandins are lipid compounds that signal pain and trigger the body’s inflammatory response. By elevating the body’s overall pain threshold, paracetamol effectively reduces the sensation of discomfort.

Furthermore, its antipyretic properties are attributed to its action on the heat-regulating center of the hypothalamus. When the body encounters infection or inflammation, the hypothalamus resets the internal "thermostat" to a higher temperature, resulting in a fever. Paracetamol facilitates peripheral vasodilation and sweating, which helps dissipate heat and return the body temperature to a normal range. This dual action makes Fevrin particularly effective for managing the systemic symptoms of viral infections, such as the common cold and influenza.

Therapeutic Applications and Indications

Fevrin is indicated for a wide array of conditions characterized by pain and elevated body temperature. Clinical data suggests that paracetamol is the preferred first-line treatment for many patients due to its superior gastric tolerance compared to NSAIDs, which can cause stomach irritation or ulcers. The primary indications for Fevrin include:

1. Cephalalgia and Migraine: It is highly effective for tension-type headaches and as a component in treating more severe migraines.
2. Odontalgia: It is frequently recommended for toothaches and post-operative dental pain.
3. Musculoskeletal Pain: This includes lower back pain, neck strain, and general muscle aches (myalgia).
4. Febrile Conditions: It is used to manage fever associated with infections or as a prophylactic measure following vaccinations.
5. Menstrual Discomfort: It provides relief for primary dysmenorrhea (painful periods).
6. Osteoarthritis: While it does not treat the underlying inflammation of joints as effectively as other drugs, it is a recommended baseline analgesic for managing the chronic pain associated with osteoarthritis.

Comprehensive Dosage and Administration Guidelines

The administration of Fevrin must be carefully calibrated based on the patient’s age, weight, and overall health status. The medication is available in two primary forms: 500 mg tablets and syrup (available in concentrations of 120 mg or 250 mg per 5 ml).

Adult and Adolescent Dosage (Ages 12 and Older)

For adults and children over the age of 12, the standard dose is 500 mg to 1,000 mg (1 to 2 tablets) every 4 to 6 hours as needed. It is critical that the total daily intake does not exceed 4,000 mg (8 tablets of 500 mg) within a 24-hour period. Exceeding this limit poses a severe risk of acute liver failure.

Pediatric Dosage (Children Under 12)

Pediatric dosing is significantly more sensitive and should ideally be calculated based on the child’s body weight (typically 10-15 mg per kilogram of body weight).

• Children 6 to 12 years: 250 mg to 500 mg (half to one tablet) three to four times daily. Alternatively, using the 250 mg/5 ml syrup, the dose is usually 5 ml to 10 ml.
• Children 1 to 6 years: Typically 120 mg to 250 mg (using the 120 mg/5 ml syrup, this equates to 5 ml to 10 ml) three to four times daily.
• Infants 3 months to 1 year: 60 mg to 120 mg (2.5 ml to 5 ml of the 120 mg/5 ml syrup) three to four times daily.

Medical professionals emphasize that Fevrin should not be administered to children under the age of two without a direct consultation and prescription from a pediatrician.

Safety Protocols and Contraindications

While paracetamol is generally considered safe, certain populations must exercise extreme caution. The primary contraindication for Fevrin is hypersensitivity or allergy to paracetamol. Additionally, individuals with severe hepatic impairment (liver disease) should avoid this medication, as the liver is the primary organ responsible for metabolizing the drug.

Pregnancy and Lactation

Fevrin is classified under Pregnancy Category B. Studies on animal models have not demonstrated a risk to the fetus, and paracetamol has been used extensively by pregnant women for decades without clear evidence of adverse outcomes. It is generally considered the safest analgesic for use during all trimesters of pregnancy and during breastfeeding. However, medical consensus dictates that it should only be used at the lowest effective dose for the shortest possible duration.

Interaction with Alcohol

Chronic alcohol consumption significantly increases the risk of paracetamol-induced hepatotoxicity. Alcohol induces certain liver enzymes that accelerate the production of NAPQI, a toxic metabolite of paracetamol. Patients are strongly advised to avoid alcohol while taking Fevrin.

Potential Side Effects and Adverse Reactions

Most individuals tolerate Fevrin well; however, side effects can occur. Common side effects are rare but may include nausea or mild stomach upset. More serious, albeit very rare, adverse reactions include:

• Hematological Issues: Such as thrombocytopenia (low platelet count) or leucopenia (low white blood cell count).
• Dermatological Reactions: Severe skin reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are rare but life-threatening emergencies. Symptoms include skin reddening, blisters, and rashes.
• Hepatotoxicity: Symptoms of liver damage include jaundice (yellowing of the skin and eyes), dark urine, and upper abdominal pain.

If a patient experiences swelling of the face, difficulty breathing, or a widespread rash, they must seek emergency medical intervention immediately, as these are signs of an anaphylactic reaction.

Drug Interactions and Complications

Fevrin can interact with other medications, potentially altering their efficacy or increasing toxicity. Notable interactions include:

• Warfarin: Long-term, high-dose use of paracetamol may enhance the anticoagulant effect of warfarin, increasing the risk of bleeding.
• Metoclopramide and Domperidone: These medications can increase the absorption rate of paracetamol.
• Cholestyramine: This can reduce the absorption of paracetamol if taken within one hour of the dose.
• Carbamazepine and Phenytoin: These anticonvulsants can increase the risk of liver damage when combined with paracetamol.

A significant risk in modern medicine is "accidental overdose" caused by the presence of paracetamol in multiple over-the-counter products. Many "all-in-one" cold and flu remedies already contain paracetamol. Patients taking Fevrin must check the labels of other medications to ensure they are not inadvertently doubling their dose.

Storage, Market Availability, and Economic Context

In the Indonesian market, Fevrin is a cost-effective solution for pain management. The 500 mg tablets are typically sold in strips, with a box of 100 tablets (10 strips) priced at approximately Rp68,200. The syrup formulation is generally priced around Rp19,148 for a 60 ml bottle. These prices make the medication accessible across various socioeconomic strata.

Proper storage is essential to maintain the chemical stability of the drug. Fevrin should be stored at room temperature (below 30°C), protected from direct sunlight and moisture. Keeping the medication in its original packaging helps prevent accidental ingestion by children, which remains a significant cause of pediatric emergency room visits.

Public Health Implications and Conclusion

The widespread availability of paracetamol-based drugs like Fevrin underscores the importance of public health education regarding self-medication. While these drugs empower individuals to manage minor ailments independently, they require a high level of health literacy. In Indonesia, the National Agency of Drug and Food Control (BPOM) monitors the safety of such medications rigorously. Recent global concerns regarding contaminants in liquid medications have led to increased scrutiny of syrup formulations, and consumers are encouraged to purchase Fevrin only from licensed pharmacies and reputable retailers.

In conclusion, Fevrin is a highly effective, versatile, and generally safe medication for the treatment of pain and fever. When used according to established guidelines—respecting the maximum daily limits and being mindful of liver health—it provides significant relief for a variety of common conditions. However, it should not be viewed as a permanent solution for chronic pain. If symptoms persist for more than three days or if pain worsens despite treatment, a consultation with a healthcare professional is mandatory to investigate potential underlying causes and to adjust the therapeutic approach. Through responsible use and adherence to medical advice, Fevrin continues to play a vital role in modern symptomatic therapy.